R. Allen Stanford, the indicted financier, sued U.S. prosecutors and agents of the FBI and Securities and Exchange Commission, accusing them of “abusive law enforcement” and seeking $7.2 billion in damages.
Cephalon Inc. , maker of the sleep- disorder drug Provigil, can’t block Mylan Inc. and Orchid Chemicals & Pharmaceuticals Ltd. from selling generic versions of the drug in Britain before a patent trial, a judge ruled.
Intel Corp.’s 1.06 billion-euro ($1.3 billion) fine for using rebates to block rivals is based on an “utterly hopeless” and untenable case by European Union regulators, company lawyers told an EU appeals court.
Eli Lilly & Co., whose best-selling schizophrenia drug Zyprexa survived a U.K. court challenge by generic makers two years ago, lost a bid to dismiss another lawsuit over the medicine’s patent in Britain.
HTC Corp., Asia’s second-largest smartphone maker, won a London court ruling against Apple Inc. over patents for touchscreen technology used for its mobile devices, including Apple’s slide-to-unlock feature.